ZACHARY KRUEGER: Open Payments
NPI 1992410898 · DYER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 19 payments from 13 companies in 2025. Trend: 2023 $542 · 2024 $1,819 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| Stryker Corporation | 2 | $102 |
| Karyopharm Therapeutics Inc. | 1 | $102 |
| Lilly USA, LLC | 1 | $100 |
| Genentech USA, Inc. | 2 | $60 |
| Celgene Corporation | 2 | $50 |
| Astellas Pharma US Inc | 2 | $39 |
| PFIZER INC. | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Syndax Pharmaceuticals, Inc. | 1 | $34 |
Products named: AUGMENT INJECTABLE, XPOVIO, JAYPIRCA, Itovebi, XTANDI, REBLOZYL, KEYTRUDA, ALUNBRIG.
Industry payments across IN — which companies pay providers there.
